z-logo
open-access-imgOpen Access
In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012–15
Author(s) -
Krystyna M. Kazmierczak,
Boudewijn L. M. de Jonge,
Gregory G. Stone,
Daniel F. Sahm
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky267
Subject(s) - ceftazidime/avibactam , avibactam , broth microdilution , ceftazidime , microbiology and biotechnology , pseudomonas aeruginosa , colistin , meropenem , efflux , biology , antimicrobial , minimum inhibitory concentration , antibiotics , medicine , antibiotic resistance , bacteria , genetics
The activity of ceftazidime/avibactam was assessed against 5716 Pseudomonas aeruginosa isolates collected from 96 medical centres in 18 European countries as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme from 2012 to 2015. Activity was analysed against subsets of isolates based on resistance phenotypes and β-lactamase content.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom